DCN VENTURES

Investment in innovation.

dcn focusses to become a reference for investment in innovation for investors who include in their investment portfolio the adequate exposure to opportunities coming out of science and innovation which are offered by the global economic change happeining in the last decades.

Personalisation of the investment recommendations for each investor, given a specific risk profile, either via investment vehicules which diversify investments in different tecnology start ups, or direct investment in start ups.

Investors benefits from the capacity dcn has to attract leading projects in innovative sectors and with the potential to go global, having access to the initiatives that are happeming in the market.

Invesment Opportunities.

Currently, dcn is rasing funds for the following investment opportunities

• Fund for Digital technologies
• Fund for Biomedicine
• Fund for Innovation
• Bags and accesories retail brand
• Premium Shoe brand
• Fashion retail chain

If you are interested in any of these investments do not hesitate to contact us.

Track record in investments in innovation.

Since its foundation in 2003, DCN has promoted and managed investment initiatives to leverage innovative projects coming from the business, scientific or academic sectors. This activity has been focused to diferent economic sectors like innovation, biomedicine, digital tecnologíes, product development and fashion. It has advised the Spanish Public Administration in the definition of the future innovation economic model to pursue within the strategic sectors of the Spanish economy.

In this moment DCN gathers more than 70 investors from Spain and USA, in three investment societies, one to invest in innovation in the biomedicine sector (Dosbio50), another to invest in digital technologies applied to the Health and Entertainment sectors (50tresdigital) and a third one to invest in innovation in any sector (Realiza). Besides promotes the creation of Corporate Venture Capital funds to strategically manage the innovation process and lately acquire the start ups. DCN applies its own Management Technologies of consolidated companies, to leverage the accelerated development of starts ups, early stage or early growth companies to become global referents.

To leverage start ups led by technology social leaders and developing differentiated technology solutions within viable business models, increasing capital in the investment societies, offering investors liquidity window and developing expected profitability by managing VC investment societies in different sectors:

• digital technologies
• biomedicine
• innovation

Investment in Digital Technologies.

Established in 2013, DCN manages this Venture Capital Investment company (50tresdigital) to invest in innovative digital tecnologies with escalability and global reach. It is powered by investors from Spain, the USA and Asia.

It gathers an advisory or scientific board formed by Adolfo Plasencia, Javier Megías, Gustavo Aranda, Juan Ángel Marín, Juan Martínez Barea, Ángel Gallego and Ignacio González Domñinguez.

Dated November 2015, DCN has signed an agreement with ITI for revaming opportunities around information technologies.

Dated April 2015, DCN and UPV (Universidad Politécnica de Valencia) have established a collaboration agreement in order to leverage the tecnology innovation ecosystem.

Dated May 2014, DCN has signed a collaboration agreement with Consejo Superior de Investigaciones Científicas (CSIC), based in Madrid, with the objective of leveraging the ecosystem around innovation. CSIC gathers more than 5.000 researchers, organized in 120 reserach groups, 40 of them in collaboration with different leading Spanish institutions.

Besides dated November 2013, dcn has signed a collaboration agreement with ESAT aiming at contributing the development of the innovation socieconomic system around innovation. Founded in 2005 in Valencia, ESAT is an educational institution dedicated to specialised training in the areas of graphic design, computer, videogames and other digital contents, lecturing on these matters. This agreement will allow to support student projects originated in the school.

It is currently invested in six start ups, Jugo dedicated to gamification focused into selfdevelopment, Encom dedicated to the generation of media contents about eSports, such as the organisation of DreamHack Valencia since 2010, Aboattime a global sailing boats chartering integrator. in eHumanlife a plataform for a second medical oponion based in Boston, MA, this last is a coinvestment with the investment society in biomedicine also managed by DCN, in Intelliment Security, dedicated to network security management and in 50x an ecommerce franchises management company.

It is currently fund raising to develop further. If you interested in investing please contact us.

Investment in Biomedicine.

Established in 2011, DCN manages this Venture Capital Investment company (Dosbio50) to invest in innovative projects of the biomedical sector, national and internationally wide. It is powered by more than 25 investors from Spain, Switzerland and USA.

It gathers an advisory or scientific board formed by José Vicente Castells Hospital la Fé de Valencia Foundation general manager, José Vicente Pons Andreu Business Innovation general manager, Manuel Pérez Alonso Universitat de Valencia doctor and professor in genetics and leader of several biomedical start ups, Eva Méndez exR&D Director at Ferrer and José Lora Executive Director of Preclinical Science at Constellation Pharma.

Dated July 2016, DCN and CIBER signed a collaboration agreement in order to leverage the innovation ecosystem in the biotech sector.

Dated July 2016, DCN and iTemas signed a collaboration agreement in order to leverage the innovation ecosystem in the health sector.

Dated July 2016, the investment society in biomedicine joined Bioval, the association of biotech companies in the Valencia region.

Dated November 2014, DCN has signed a collaboration agreement with Hospital San Joan de Dèu in Barcelona, number one hospital in Spain in Children Care.

Dated May 2014, DCN has signed a collaboration agreement with Instituto de Investigación Sanitaria La Fe, based in Valencia at Hospital La Fe, with the objetive of leveraging the Spanish innovation ecosystem. This Institute has a long time track of scientific results, leveraging translational research at its location within the Hospital La Fe, an international reference.

Also dated May 2014, DCN has signed a collaboration agreement with Consejo Superior de Investigaciones Científicas (CSIC), based in Madrid, with the objective of leveraging the ecosystem around innovation. CSIC gathers more than 5.000 researchers, organized in 120 reserach groups, 40 of them in collaboration with different leading Spanish institutions.

Also dated May 2014, DCN has signed a collaboration agreement with Centro de Investigación Príncipe Felipe (CIPF), based in Valencia, with the objetive of leveraging the Spanish innovation ecosystem. CIPF has suffered a deep transformation due to the cuts of the Spanish administration, but it is relaunched to a new stage to leverage the research around biomedicine.

During September 2013, dcn has signed a collaborative agreement with the Instituto Ramón y Cajal de investigación Sanitaria (Irycis) belonging to Hospital Ramón y Cajal located in Madrid with the goal to leverage a more effective biomedicine research.

Besides dcn has a collaboration agreement with Metasbio to validate the technologies under investment evaluation.

It is currently invested in seven companies bioncotech therapeutics, in Nuubo, in Artax Biopharma, in eHumanlife , this last is a coinvestment with the investment society in digital tecnologies also managed by DCN, these last two based in Boston MA, in Bionurebased in BCN and SFO, in Universal Diagnostic, based in Sevilla and Boston, MA, and in Pharmacelera based in BCN.

It is currently fund raising to develop further. If you interested in investing please contact us.

Investment in innovation.

Establised in 2007 by DCN power and that of other businesspeople, DCN manages a Venture Capital investment company (Realiza Business Angels ), which currently gathers more than 20 investors interested in the development of innovative companies of any sector, national and internationally wide.

After studying more than 1500 innovative projects of any field, Realiza invested in 18 of them. Currently is still investing in 13 projects SFP, imegen, dosbio50, bioncotech therapeutics, 50tresdigital, Jugo, Encom, Consultia, Artax Biopharma, Beroomers, Universal Diagnostic, Nextail and weplan.

DCN manages the attraction and analysis of projects, invest, gives support to the management of the invested companies and deinvest.

This company has already deinvested in five start ups, Photomiracle, Energía Geotérmica, Moldea, Mexquemai and Canales Corporativos, and partially in Jugo.

It is currently fund raising to develop further. If you interested in investing please contact us.

Agreements with finantial institutions and other players.

Dcn keeps strong links with the main Spanish finantial institutions in order to jointly consolidate the innovation ecosystem.

Dated January 2015, DCN has established a collaboration agreement with Banco Sabadell, in order for companies invested by investment societies managed by DCN, or advised clients by DCN, have preferred access to financing.

Dated December 2012, DCN has been selected by ENISA as qualified investor for the Fund Spain Start Up budgeted with €20M per year, until December 2014. This is a selected list of less than 50 Spanish investment management companies, within which DCN is honoured, recognising its referent position as a management company since its constitution back in 2003. The goal pursued by the Spanish Ministry of Industry and Innovation is that the administration co invests in innovative start ups aligned with qualified investors and with those who invest with them. The co investment consists in participative loans in attractive conditions of up to the amount of equity invested by qualified investors and its co investors.

Dated February 2013 Fundación Bankinter and DCN have signed a two years collaboration agreement, aiming at leveraging and consolidating innovation by developing the entrepreneurial ecosystem, empowering Spanish companies able to become global tecnological leaders and working together to ease the access to resources in the initial stages of development of start ups. This collaboration with Fundación Bankinter means another step to consolidate DCN mission as management support for Spanish companies aiming at global positioning.

Dated February 2014, DCN has established a collaborative agreement with the technology companies accelerator, Top Seed Lab based in Madrid, led by Ignacio Macías and which is developing new mechanisms for the emergence of disruptive projects and which has gathered the most consolidated players in the Madrid ecosystem around innovation. The collaboration pretends to link an accelerator and a series of follow up funds to invest in innovation in its early stages increasing the efficiency that different agents are bringing into innovative projects with potential, which are florishing from the scientific, academic or business environment.

Dated February 2015 DCN has reinforced an alliance with Instituto de Empresa at Madrid, becoming Investor in Residence with permanent presence at IE site in Madrid. Besides in 2014, the collaboration was already intensified with Instituto de Empresa to share dealflow of innovative projects and to organise IE Venture Network in Valencia.

Need finance for your innovation project?

If you are a scientist or an entrepreneur, and you have an idea, a project or a running company and need help, do not hesitate to contact us.

Want to invest in Venture Capital?

If you are an investor interested in contributing to the development of the innovation sectors in Spain and you are looking to invest in Venture Capital companies or in innovative projects, please contact us, DCN might have the opportunity you are looking for co – investing with us in any of the investment companies DCN runs or invest in any of the projects we manage.

Do you want to promote your own Corporate Venture Capital?

If your company needs to manage radical innovation in those sectors in which future sustainability of your business might be, DCN can manage your Corporate Venture Capital investment society adapted to your specific business needs, depending on the sector you compete, future technologies to be explored, your available investment capacity, and the economic and strategic goals of your company.